[PHARMA] YoY Quarter Result on 31-Dec-2012 [#4]

Announcement Date
18-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- -131.43%
YoY- -166.44%
Quarter Report
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 680,150 627,103 567,860 482,404 367,786 376,116 323,906 13.15%
PBT 23,717 37,854 33,007 4,248 16,368 -2,701 27,490 -2.42%
Tax -7,676 -1,233 -11,740 -11,716 -4,186 749 -5,372 6.12%
NP 16,041 36,621 21,267 -7,468 12,182 -1,952 22,118 -5.21%
-
NP to SH 16,062 36,697 20,813 -7,934 11,942 -2,256 21,914 -5.04%
-
Tax Rate 32.36% 3.26% 35.57% 275.80% 25.57% - 19.54% -
Total Cost 664,109 590,482 546,593 489,872 355,604 378,068 301,788 14.04%
-
Net Worth 529,786 525,351 486,672 472,037 514,153 421,262 431,217 3.48%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 18,134 31,055 16,049 11,771 35,296 - 39,590 -12.19%
Div Payout % 112.90% 84.63% 77.11% 0.00% 295.57% - 180.66% -
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 529,786 525,351 486,672 472,037 514,153 421,262 431,217 3.48%
NOSH 259,064 258,794 258,868 117,715 117,655 106,919 107,001 15.87%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 2.36% 5.84% 3.75% -1.55% 3.31% -0.52% 6.83% -
ROE 3.03% 6.99% 4.28% -1.68% 2.32% -0.54% 5.08% -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 262.54 242.32 219.36 409.81 312.60 351.78 302.71 -2.34%
EPS 6.20 14.18 8.04 -6.74 10.15 -2.11 20.48 -18.04%
DPS 7.00 12.00 6.20 10.00 30.00 0.00 37.00 -24.22%
NAPS 2.045 2.03 1.88 4.01 4.37 3.94 4.03 -10.68%
Adjusted Per Share Value based on latest NOSH - 117,715
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 51.95 47.90 43.38 36.85 28.09 28.73 24.74 13.15%
EPS 1.23 2.80 1.59 -0.61 0.91 -0.17 1.67 -4.96%
DPS 1.39 2.37 1.23 0.90 2.70 0.00 3.02 -12.12%
NAPS 0.4047 0.4013 0.3718 0.3606 0.3927 0.3218 0.3294 3.48%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 6.36 4.58 4.45 8.10 5.36 5.31 4.00 -
P/RPS 2.42 1.89 2.03 1.98 1.71 1.51 1.32 10.62%
P/EPS 102.58 32.30 55.35 -120.18 52.81 -251.66 19.53 31.82%
EY 0.97 3.10 1.81 -0.83 1.89 -0.40 5.12 -24.20%
DY 1.10 2.62 1.39 1.23 5.60 0.00 9.25 -29.86%
P/NAPS 3.11 2.26 2.37 2.02 1.23 1.35 0.99 21.00%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 15/02/16 23/02/15 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 -
Price 6.19 5.28 4.29 7.80 5.90 5.35 4.05 -
P/RPS 2.36 2.18 1.96 1.90 1.89 1.52 1.34 9.88%
P/EPS 99.84 37.24 53.36 -115.73 58.13 -253.55 19.78 30.95%
EY 1.00 2.69 1.87 -0.86 1.72 -0.39 5.06 -23.67%
DY 1.13 2.27 1.45 1.28 5.08 0.00 9.14 -29.40%
P/NAPS 3.03 2.60 2.28 1.95 1.35 1.36 1.00 20.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment